
    
      The prospective observation period per patient will be up to 24 months. A minimum of one
      follow-up visit per year is required in order to maintain patient's participation in the
      study.

      The baseline visit will be used to assess eligibility and collect baseline characteristics
      information. The follow-up visits will take place at a frequency defined as per
      investigator's discretion.

      The study eye is defined as the first eye treated during the study, the other eye will be
      considered as the fellow eye. If both eyes are treated at baseline, the right eye will be
      chosen as the study eye.
    
  